These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38539538)

  • 61. ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas: Clinicopathologic and Molecular Analysis of 4 Cases and Literature Review.
    Agaimy A; Baněčková M; Ihrler S; Mueller SK; Franchi A; Hartmann A; Stoehr R; Skálová A
    Am J Surg Pathol; 2021 Sep; 45(9):1166-1178. PubMed ID: 33871952
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor alpha in salivary duct carcinoma.
    Fan CY; Melhem MF; Hosal AS; Grandis JR; Barnes EL
    Arch Otolaryngol Head Neck Surg; 2001 Sep; 127(9):1075-9. PubMed ID: 11556855
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Salivary duct carcinoma--a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression.
    Skálová A; Stárek ; Kucerová V; Szépe P; Plank L
    Pathol Res Pract; 2001; 197(9):621-6. PubMed ID: 11569926
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Salivary Duct Carcinoma: An Aggressive Salivary Gland Carcinoma with Morphologic Variants, Newly Identified Molecular Characteristics, and Emerging Treatment Modalities.
    Rahman M; Griffith CC
    Surg Pathol Clin; 2021 Mar; 14(1):111-126. PubMed ID: 33526216
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.
    Krishnamurthy J; Krishnamurty DM; Baker JJ; Zhen W; Lydiatt D; Ganti AK
    Head Neck; 2013 Dec; 35(12):E372-5. PubMed ID: 23765450
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience.
    Laughlin BS; Ebrahimi S; Voss MM; Patel SH; Foote RL; McGee LA; Garcia J; Ma DJ; Garces YI; Wittich MAN; Price KA; Schmitt A; Zhai Q; May BC; Nagel TH; Hinni ML; Chintakuntlawar AV; DeWees TA; Rwigema JM
    Adv Radiat Oncol; 2023; 8(4):101204. PubMed ID: 37152485
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Solitary late spinal metastasis from apocrine salivary duct carcinoma: Case report.
    Baldassarre BM; Penner F; Bertero L; Di Perna G; Ajello M; Marengo N; Zenga F; Garbossa D
    Surg Neurol Int; 2021; 12():122. PubMed ID: 33880227
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report.
    Yang ZY; Huang JH; Chen B; Xu CW; Lei L; Wang XJ; Fang MY
    Front Oncol; 2020; 10():559057. PubMed ID: 33123470
    [No Abstract]   [Full Text] [Related]  

  • 69. The tumor immune contexture of salivary duct carcinoma.
    Schvartsman G; Bell D; Rubin ML; Tetzlaff M; Hanna E; Lee JJ; Weber R; Phan J; Glisson BS; Ferrarotto R
    Head Neck; 2021 Apr; 43(4):1213-1219. PubMed ID: 33576119
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Androgen Receptor Expression in Primary Nonsquamous Cell Rare-Variant Carcinomas of the Head and Neck.
    Rahimi S; Bradley KL; Akaev I; Marani C; Yeoh CC; Brennan PA
    OTO Open; 2017; 1(2):2473974X17715633. PubMed ID: 30480186
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma.
    Kapadia SB; Barnes L
    Mod Pathol; 1998 Nov; 11(11):1033-8. PubMed ID: 9831198
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
    Williams MD; Roberts D; Blumenschein GR; Temam S; Kies MS; Rosenthal DI; Weber RS; El-Naggar AK
    Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Salivary Duct Carcinoma of the Parotid Gland Originating from an Epithelial-Myoepithelial Carcinoma: Report of a Rare Case.
    Hamamoto Y; Harada H; Suzuki M; Fujii T; Nakatsuka SI
    Head Neck Pathol; 2020 Mar; 14(1):283-289. PubMed ID: 30937832
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.
    Williams L; Thompson LD; Seethala RR; Weinreb I; Assaad AM; Tuluc M; Ud Din N; Purgina B; Lai C; Griffith CC; Chiosea SI
    Am J Surg Pathol; 2015 May; 39(5):705-13. PubMed ID: 25871467
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A 22-year single institution review of 119 cases of salivary duct carcinoma.
    Han EJ; Mukdad LA; Alhiyari Y; Nakhla MN; Sajed DP; St John MA
    Laryngoscope Investig Otolaryngol; 2024 Apr; 9(2):e1234. PubMed ID: 38525121
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human Epidermal Growth Factor Receptor 2 (HER2/neu) in Salivary Gland Carcinomas: A Review of Literature.
    Alotaibi AM; Alqarni MA; Alnobi A; Tarakji B
    J Clin Diagn Res; 2015 Feb; 9(2):ZE04-8. PubMed ID: 25859537
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry.
    Skálová A; Stárek I; Vanecek T; Kucerová V; Plank L; Szépe P; Di Palma S; Leivo I
    Histopathology; 2003 Apr; 42(4):348-56. PubMed ID: 12653946
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Low-grade salivary duct carcinoma of the parotid gland: report of a case with immunohistochemical analysis.
    Kusafuka K; Itoh H; Sugiyama C; Nakajima T
    Med Mol Morphol; 2010 Sep; 43(3):178-84. PubMed ID: 20857268
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.
    Yamamoto H; Uryu H; Segawa Y; Tsuneyoshi M
    Pathol Int; 2008 May; 58(5):322-6. PubMed ID: 18429833
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma.
    Hoang MP; Callender DL; Sola Gallego JJ; Huang Z; Sneige N; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2001 Oct; 19(4):865-71. PubMed ID: 11562768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.